Anti-Spike protein [Ty1], Human IgA-Fc Fusion,, Monoclonal

Artikelnummer: ABA-AB02061-16.159
Artikelname: Anti-Spike protein [Ty1], Human IgA-Fc Fusion,, Monoclonal
Artikelnummer: ABA-AB02061-16.159
Hersteller Artikelnummer: Ab02061-16.159
Alternativnummer: ABA-AB02061-16.159
Hersteller: Absolute Antibody
Wirt: Human
Kategorie: Antikörper
Applikation: BLI, ELISA, FA, FC, IF
Spezies Reaktivität: Virus
Alternative Synonym: SARS CoV 2 S glycoprotein, COVID-19 Spike protein, RBD, Receptor Binding Domain, E2 glycoprotein, E2, Human coronavirus 2 spike glycoprotein, Peplomer protein, S glycoprotein, SARS coronavirus 2 S protein, SARS coronavirus 2 Spike Protein, SARS CoV 2 Spike protein, SARS CoV 2, SARS-CoV-2 S protein, SARSCoV2, SARS-COV-2 S protein, SARS-COV-2 Spike glycoprotein, SARSCOV2 Spike protein, Severe acute respiratory syndrome 2 spike glycoprotein, Severe acute respiratory syndrome virus 2 spike glycoprotein, Spike glycoprotein, 2019-nCoV, TY-1
The original antibody was generated by immunizing an adult male alpaca. Four rounds of immunizations were carried out during a 60 day period. For the first two rounds SARS-CoV-2 S1-sheep-FC was used as an antigen and for the last two rounds SARS-CoV-2 RBD was used as an immunogen. Selection of specific binders was done by two consecutive rounds of phage display and panning against RBD immobilized on magnetic beads.
Klonalität: Monoclonal
Klon-Bezeichnung: [Ty1]
Isotyp: IgA-Fc Fusion
UniProt: P0DTC2
Puffer: PBS with 0.02% Proclin 300.
Quelle: Dromedary
Target-Kategorie: Spike protein